SCHEMBL4512432

SCHEMBL4512432

COc1cc(Cn2c(C)cc(O)cc2=O)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ LMNA P02545 7/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ GAA P10253 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CCR2 P41597 2/20 0.41
▸ ABCB11 O95342 1/20 0.40
▸ HTT P42858 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ PDE1A P54750 1/20 0.38
▸ PDE1B Q01064 1/20 0.38
▸ PDE1C Q14123 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ MAPT P10636 4/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501972 0.90 POLB (0.47) POLBLMNASMN1; SMN2GAATDP1
SCHEMBL4376098 0.82 ALDH1A1 (0.57) POLBLMNAALDH1A1MEN1KMT2A
SCHEMBL4510612 0.81 GAA (0.41) LMNASMN1; SMN2GAATDP1CCR2
SCHEMBL24645041 0.79 POLB (0.59) POLBLMNASMN1; SMN2GAATDP1
SCHEMBL24645033 0.76 POLB (0.56) POLBLMNASMN1; SMN2GAATDP1
SCHEMBL24645139 0.76 POLB (0.56) POLBLMNASMN1; SMN2GAATDP1
SCHEMBL4496903 0.76 MIF (0.55) POLBLMNAALDH1A1TSHRMEN1
SCHEMBL4392970 0.76 LMNA (0.60) POLBLMNASMN1; SMN2ALDH1A1TSHR
SCHEMBL4507491 0.75 MIF (0.54) POLBLMNAHTTMEN1KMT2A
SCHEMBL4516793 0.73 POLB (0.48) POLBLMNAGAATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 — — US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 — — US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 — — US disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 POLB 619/4885LMNA 2954/4885SMN1; SMN2 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback